Target intelligence / Profile preview

Aminopeptidase from Aeromonas proteolytica (AAP)

Target
AAP
Molecular classification
Enzyme, Metalloenzyme, Aminopeptidase, Zinc-dependent protease, Hydrolase, Binuclear zinc enzyme
01

Overview

Aminopeptidase from Aeromonas proteolytica (AAP) is a prototypical bacterial metalloenzyme that catalyzes the sequential removal of N-terminal amino acids from peptides and proteins. It is notable for containing a dinuclear (two zinc ions) active site with equivalent roles in catalysis, making it a model system for studying co-catalytic mechanisms in metallohydrolases. AAP is a monomeric hydrolase of approximately 29.5 kDa, highly stable under a range of conditions, with broad substrate specificity for hydrophobic N-terminal residues. Its well-characterized structure and mechanism make it important for studies in enzymology, inhibitor design, and as a representative for understanding bacterial aminopeptidases, though it is not itself a direct human drug target.

Other names
Aeromonas proteolytica aminopeptidaseAAPAeromonas aminopeptidaseAeromonas proteolytica leucine aminopeptidase
02

Mechanism of action

Inhibitors act by chelating the catalytic zinc ions or by binding to the active site and blocking substrate access.

03

Biological functions

Protein degradationMetabolism of peptidesHydrolysis of N-terminal amino acids from polypeptides and proteinsPeptide digestionProtein maturation
04

Disease associations

Infection (as a bacterial enzyme, involved in bacterial peptide metabolism)Other (potential roles in biotechnology and as a model enzyme for inhibitor design)Not directly associated with human diseases
05

Safety considerations

None relevant for human therapeutic use, as this is a bacterial enzyme not targeted in clinical medicine.Laboratory safety practices should be followed when handling the purified enzyme.
06

Interacting drugs

No approved drugs target this bacterial enzyme in clinical settings; however, general aminopeptidase inhibitors (e.g., bestatin) have been used in laboratory studies
07

Biomarkers

None known for clinical use; not used as a biomarker in humans.May serve as a biochemical marker in bacterial or enzymology research.

Beyond the preview

Go deeper on Aminopeptidase from Aeromonas proteolytica (AAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aminopeptidase from Aeromonas proteolytica (AAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call